Real-world data on change in work productivity, activity impairment, and quality of life in patients with psoriatic arthritis under anti-TNF therapy: a postmarketing, noninterventional, observational study


KARADAĞ Ö. , DALKILIÇ H. E. , AYAN G. , KÜÇÜKŞAHİN O., KAŞİFOĞLU T., Yilmaz N., ...More

CLINICAL RHEUMATOLOGY, 2021 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Publication Date: 2021
  • Doi Number: 10.1007/s10067-021-05893-3
  • Title of Journal : CLINICAL RHEUMATOLOGY
  • Keywords: Anti-TNF, ACR20/50/70, DAPSA28, DAS28, Psoriatic arthritis, Work disability, CERTOLIZUMAB PEGOL, CLINICAL-RESPONSE, DISEASE-ACTIVITY, DOUBLE-BLIND, PHASE-III, GOLIMUMAB, SAFETY, TRIAL, MULTICENTER, ETANERCEPT

Abstract

Objectives To understand change in work productivity, activity impairment, quality of life (QoL), and disease activity in patients with psoriatic arthritis (PsA) receiving anti-tumor necrosis factor (anti-TNF) treatment.